1-[(4-methyl-1,3-thiazol-2-yl)methyl]piperazine hydrochloride, 95.0%, 2.5g

6-FLUORO-5-NITRO-1H-INDOLE, 95.0%, 1g

Infinity corrected plan PL-M 5x/0.14 IOS objective. Working distance 20.5 mm

tert-Butyl Aminosulfonylcarbamate, 97.0%, 25g

Methyl (3-bromophenyl)carbamate, 95.0%, 100mg

3-Ethoxy-2-fluorobenzaldehyde, 95%, 100mg

[(4-fluorophenyl)amino](oxo)acetic acid, 95.0%, 1g

L(+)-lactic acid, calcium salt pentahydrate, min. 98%, 500 g, plastic packaging.

6-Methylbenzofuran-2-carboxylic acid, 98+%, 100mg

(1-(2-Methoxy-2-oxoethyl)-1H-pyrazol-4-yl)boronic acid, 95%, 1g

1-(tert-Butoxycarbonyl)indolin-6-yl-6-boronic acid, 98%, 250mg

(2S)-2-[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-methylbutanamido]-5-(carbamoylamino)pentanoic acid, 98%, 5g

1-(4-Amino-2-chlorophenyl)-4-methylpiperazine trihydrochloride, 95.0%, 1g